Author
Listed:
- Evan S. O’Brien
(Stanford University School of Medicine)
- Vipin Ashok Rangari
(University of Health Sciences and Pharmacy at St Louis and Washington University School of Medicine)
- Amal El Daibani
(University of Health Sciences and Pharmacy at St Louis and Washington University School of Medicine)
- Shainnel O. Eans
(University of Florida)
- Haylee R. Hammond
(University of Florida)
- Elizabeth White
(Stanford University School of Medicine)
- Haoqing Wang
(Stanford University School of Medicine)
- Yuki Shiimura
(Stanford University School of Medicine
Kurume University)
- Kaavya Krishna Kumar
(Stanford University School of Medicine)
- Qianru Jiang
(University of Health Sciences and Pharmacy at St Louis and Washington University School of Medicine)
- Kevin Appourchaux
(University of Health Sciences and Pharmacy at St Louis and Washington University School of Medicine)
- Weijiao Huang
(Stanford University School of Medicine)
- Chensong Zhang
(SLAC National Acceleration Laboratory)
- Brandon J. Kennedy
(Princeton University)
- Jesper M. Mathiesen
(University of Copenhagen)
- Tao Che
(University of Health Sciences and Pharmacy at St Louis and Washington University School of Medicine)
- Jay P. McLaughlin
(University of Florida)
- Susruta Majumdar
(University of Health Sciences and Pharmacy at St Louis and Washington University School of Medicine)
- Brian K. Kobilka
(Stanford University School of Medicine)
Abstract
The µ-opioid receptor (µOR) is a well-established target for analgesia1, yet conventional opioid receptor agonists cause serious adverse effects, notably addiction and respiratory depression. These factors have contributed to the current opioid overdose epidemic driven by fentanyl2, a highly potent synthetic opioid. µOR negative allosteric modulators (NAMs) may serve as useful tools in preventing opioid overdose deaths, but promising chemical scaffolds remain elusive. Here we screened a large DNA-encoded chemical library against inactive µOR, counter-screening with active, G-protein and agonist-bound receptor to ‘steer’ hits towards conformationally selective modulators. We discovered a NAM compound with high and selective enrichment to inactive µOR that enhances the affinity of the key opioid overdose reversal molecule, naloxone. The NAM works cooperatively with naloxone to potently block opioid agonist signalling. Using cryogenic electron microscopy, we demonstrate that the NAM accomplishes this effect by binding a site on the extracellular vestibule in direct contact with naloxone while stabilizing a distinct inactive conformation of the extracellular portions of the second and seventh transmembrane helices. The NAM alters orthosteric ligand kinetics in therapeutically desirable ways and works cooperatively with low doses of naloxone to effectively inhibit various morphine-induced and fentanyl-induced behavioural effects in vivo while minimizing withdrawal behaviours. Our results provide detailed structural insights into the mechanism of negative allosteric modulation of the µOR and demonstrate how this can be exploited in vivo.
Suggested Citation
Evan S. O’Brien & Vipin Ashok Rangari & Amal El Daibani & Shainnel O. Eans & Haylee R. Hammond & Elizabeth White & Haoqing Wang & Yuki Shiimura & Kaavya Krishna Kumar & Qianru Jiang & Kevin Appourchau, 2024.
"A µ-opioid receptor modulator that works cooperatively with naloxone,"
Nature, Nature, vol. 631(8021), pages 686-693, July.
Handle:
RePEc:nat:nature:v:631:y:2024:i:8021:d:10.1038_s41586-024-07587-7
DOI: 10.1038/s41586-024-07587-7
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:631:y:2024:i:8021:d:10.1038_s41586-024-07587-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.